chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09May2022 at 12:00 as dose 4 (booster), single (Lot number: FP4554) at the age of 57 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results. Therapeutic measures were taken as a result of covid-19.  Clinical course: The patient received vaccine. The patient did not receive other medication in 2weeks. Anti-viral details: The patient received treatment with Paxlovid from 28May2022 to 01Jun2022 for treatment of COVID-19. Adverse event: paxlovid recurring symptoms on day 10 from 06Jun2022 at 12:00 AM. The patient was not recovered . No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Feb2021 at 07:15 as dose 1, single (Lot number: EN6201), in right arm, on 26Feb2021 at 06:45 as dose 2, single (Lot number: EN6201), in right arm, on 27Sep2021 at 17:15 as dose 3 (booster), single (Lot number: FF8839), in right arm and on 06Apr2022 at 17:15 as dose 4 (booster), single (Lot number: FK9895) at the age of 68 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Breast cancer" (unspecified if ongoing); "Known Allergies: Penicillin" (unspecified if ongoing); "Known Allergies: peanut Products" (unspecified if ongoing); "Known Allergies: Oil/Food" (unspecified if ongoing); "Known Allergies: Dust" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Covid Rebound; Positive, notes: Currently day 9 with with positive test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Addition information: Covid Rebound with heavy nasal congestion, sore throat and sneezing on day 8 after 5 day treatment with Paxlovid beginning on day 1 of symptoms/positive test; also nasty metallic taste in mouth days 1-5 while taking Paxlovid. Currently day 9 with positive test and heavy sinus/throat symptoms. Treatment start date was 29May2022. Treatment stop date was 02Jun2022.; Sender's Comments: The reported Covid 19 positive after both the doses of  COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Apr2021 as dose 1, single (Lot number: EW0170), in left arm, on 15May2021 as dose 2, single (Lot number: EW0183), in left arm and on 29Dec2021 as dose 3 (booster), single (Lot number: FJ1611) at the age of 36 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Graves Disease" (unspecified if ongoing), notes: Graves Disease with active hyperthyroidism; "hyperthyroidism" (unspecified if ongoing), notes: Graves Disease with active hyperthyroidism. Concomitant medication(s) included: METHIMAZOLE, start date: 06Oct2021; CITALOPRAM, start date: 01Dec2021; GUANFACINE, start date: 01Dec2021. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 29May2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29May2022) Positive, notes: symptoms were nearly gone but covid test was positive (very pale pink); (31May2022) Positive, notes: symptoms came back fully and tested positive (solid pink). Therapeutic measures were taken as a result of vaccination failure, covid-19.  Addition information: Treatment start date was 24May2022. Treatment stop date was 29May2022. Known allergies was no.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 07Mar2021 as dose 1, single (Lot number: EN6202), in left arm, on 28Mar2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 27Oct2021 as dose 3 (booster), single (Lot number: FF2587), in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 25Apr2022 as dose 4 (booster), single (Lot number: 057M21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Jun2022) Negative, notes: my last negative test; (06Jun2022) Positive, notes: Tested positive on a home test. Therapeutic measures were taken as a result of drug ineffective, covid-19.   Clinical course: Patient had no known allergies. Patient was not received other medication in 2 weeks. Anti-viral details: product=COVID 19 Treatment, brand=Paxlovid, Treatment start date= 28May2022, Treatment stop date= 01Jun2022, Indication=Treatment of COVID-19. Relapse on 06Jun2022, 5 days after stopping Paxlovid, 4 days after her last negative test. Headache and runny nose. Tested positive on a home test.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Tested positive; Tested positive; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Apr2021 as dose 1, single (Lot number: ER8732), in left arm, on 26Apr2021 as dose 2, single (Lot number: GR8731), in left arm and on 05Nov2021 as dose 3 (boosster), single (Lot number: 320308D) at the age of 53 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 24Apr2022 as dose 4 (booster), single (Lot number: 057M21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Sulfa". There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 02May2022, outcome "recovered" (20May2022) and all described as "Tested positive". Patient became sick with Covid. Tested positive on 02May2022. Experienced symptoms before testing positive. Symptoms included fever, chills, vomiting, diarrhea, sore throat, cough, and then secondary infection which was treated with Azithromycin, albuterol, benzonatate. Strange thing was patient seemed to improve, tested negative for three days in May2022, and then her symptoms returned on 13May and she tested positive again for more than a week. Adverse event treatment included received Paxlovid then other meds after rebound.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 19Feb2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 12Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 72 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "allergies" (unspecified if ongoing), notes: known allergies Yes. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old male patient received BNT162b2 (BNT162B2), on 04Dec2021 as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29May2022) Negative; (06Jun2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received other medication in 2 weeks. Patient received Paxlovid (anti viral) from 24May2022 to 29May2022 for COVID-19 treatment. Paxlovid rebound - after testing negative on 29May2022, symptomatic on 04Jun2022 and tested positive again on 06Jun2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: positive antigen test; positive antigen test; This is a spontaneous report received from a non-contactable Physician. The reporter is the patient. A 27-year-old female patient (unknown if pregnant) received BNT162b2 (BNT162B2), on 11Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 27 years for covid-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). There were no concomitant medications. Patient did not have other medication in 2weeks. It was reported that day 6 after completion of Paxlovid (day 11 after positive antigen test) developed rhinorrhea, and antigen test was again positive (after negative on day 7). The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Positive; (unspecified date) Negative; (06Jun2022) again Positive. Patient received Paxlovid from 27May2022 to 31May2022 for Treatment of COVID-19. Outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information provided, known drug safety profile and plausible temporal association, the causality between BNT162B2 and the reported events drug ineffective and Covid 19 cannot be completely excluded.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Apr2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 37 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19. The Anti-viral with Paxlovid started on 20May2022 till 25May2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccination failure
Clinical narrative: COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old male patient received BNT162b2 (BNT162B2), on 15Apr2021 as dose 1, single (Lot number: Ew0162), on 06May2021 as dose 2, single (Lot number: Ew0165) and on 13Dec2021 as dose 3 (booster), single (Lot number: Fj1611) at the age of 34 years for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing); "Sleep Apnea" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Regalin with an intolerance to seafood" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient started Paxlovid (lot Fy9918) on 04Jun2022 as COVID 19 treatment.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID-19 infection Omicron variant; COVID-19 infection Omicron variant; This is a spontaneous report received from non-contactable consumer.  An 11-year-old male patient received BNT162b2 (BNT162B2), on 06Nov2021 as dose 1, single (Batch/Lot number: unknown) and in Nov2021 as dose 2, single (Batch/Lot number: unknown) at the age of 11 years, all intramuscular for COVID-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 27Dec2021, outcome "recovered" and all described as "COVID-19 infection Omicron variant". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27Dec2021) Positive, notes: Omicron variant. Therapeutic measures were not taken as a result of drug ineffective, COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID infection; COVID infection; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP).  An 11-year-old male patient received BNT162b2 (BNT162B2), on 06Nov2021 as dose 1, single (Batch/Lot number: unknown) and in Nov2021 as dose 2, single (Batch/Lot number: unknown), all intramuscular for COVID-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient's concomitant medications were not reported. It was unknown whether the patient received any other vaccine within 4 weeks prior to the vaccine.   The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "recovered" and all described as "COVID infection". The patient underwent the following laboratory tests and procedures: COVID-19 PCR test (nasal swab) in May2021, which was positive. It was unknown if therapeutic measures were taken as a result of drug ineffective and COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: reported that her family all came down with COVID;  reported that her family all came down with COVID; This is a spontaneous report received from a contactable reporter (Physician/Pfizer Colleague).  A patient (no qualifiers provided) received BNT162b2 (COMIRNATY), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as reported that her family all came down with COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Additional information: Vaccination status unknown as of 05Apr2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The efficacy of a product varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect product BNT162b2 to the reported events drug ineffective and COVID-19 cannot be ruled out.
Age: 42.0
Sex: M
Vaccine: COVID19, FLUX
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Tested positive for Covid on rapid test.; Tested positive for Covid on rapid test.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old male patient received BNT162b2 (BNT162B2), on 08Mar2021 as dose 1, single (Lot number: EL3247), in left arm, on 29Mar2021 as dose 2, single (Lot number: EL3247), in left arm and on 27Nov2021 as dose 3 (booster), single (Lot number: FJ1620) at the age of 42 years, in left arm for covid-19 immunisation; influenza vaccine (FLU), on 27Nov2021 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "no" (unspecified if ongoing), notes: Other Medical History: No, Known allergies: No. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 07Jun2022 at 17:15, outcome "not recovered" and all described as "Tested positive for Covid on rapid test.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Jun2022) Positive, notes: Nasal Swab Tested positive for Covid on rapid test. Therapeutic measures were not taken as a result of vaccination failure, covid-19.  Clinical course: Reported as, the patient was not diagnosed with COVID-19 prior to vaccination. He had been tested for COVID-19 since the vaccination. He had taken other vaccine (Flu vaccine) in four weeks.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Fever; headache; chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 5-year-old male patient received BNT162b2 (COMIRNATY), on 05Jun2022 as dose 1, single (Batch/Lot number: unknown) at the age of 5 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious) with onset Jun2022, outcome "unknown", described as "Fever"; CHILLS (non-serious) with onset Jun2022, outcome "unknown"; HEADACHE (non-serious) with onset Jun2022, outcome "unknown".  Additional information: There were no known allergies. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Macule
Clinical narrative: Developed a red spot on her left side; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the parent.  A female patient received BNT162b2 (BNT162B2), on 03Jun2022 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MACULE (non-serious) with onset 03Jun2022, outcome "unknown", described as "Developed a red spot on her left side".  Additional information: It was reported that the caller stated that she took her daughter to get the Pfizer COVID-19 vaccine first dose on Friday but didn't mention the specific date. She stated that overnight right above her temple, she developed a red spot on her left side. She asked if she needed to be worried and she was afraid that she might die in front of her.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Taste disorder
Clinical narrative: Systemic: experienced changes in taste-Mild
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Taste disorder
Clinical narrative: Systemic: pt report changes in taste 3 days after the vaccination-Mild
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash
Clinical narrative: Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Lymph Node Swelling-Medium, Additional Details: Patient was having rash the following day on the lower extremities, and swollen lympnodes
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site vesicles
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: friend came in with a picture of her arm.  it was red, spotchy and blistered.  recommended pt go to urgent care or er in case of cellulitus
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Heart rate irregular, Hyperhidrosis, Nausea, Pallor
Clinical narrative: Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild, Additional Details: about 1 minutes after covid 19 Pfiezer 5-11 yrs vaccine, patient complains of nausea. look pale on face. no fever. sweat a little bit. patient is responsive. Blood pressure was 58/43, heartbeat 55. mother was give her a sip of drink which she brought with her. After 15 minutes blood pressure was taken again at 91/77. heartbeat 84. patient looks almost back to normal.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Deafness bilateral
Clinical narrative: Systemic: HEARING LOSS, BOTH EARS-Severe, Additional Details: PATIENT DEVELOPED HEARING LOSS WITHIN 2 HOURS OF ADMINISTRATION THAT HAS YET TO SUBSIDE. PATIENT HAS VISIT WITH AUDIOLOGIST LATER THIS WEEK TO ACCESS THE SITUATION.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain, Pain
Clinical narrative: Site: Pain at Injection Site-Medium, Additional Details: Patient is having shoulder pain. Had the normal soreness the first few days but pain started happening with shoulder movement after a few days. Has not seen the doctor. I advised them to call. On their way out of town and planning on calling doctor when they arrive.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia, Paraesthesia oral, Swelling face
Clinical narrative: Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Tingling starting in hand but has improved. Tingling, numbness and puffiness in left side of mouth.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Anticoagulant therapy, Blood creatinine increased, COVID-19, Chest X-ray abnormal
Clinical narrative: Patient is fully vaccinated. COVID positive on 5/9/2022. 67-year-old female, history of end-stage renal disease on peritoneal dialysis daily, CAD hypertension hyperlipidemia, COPD and CHF, oxygen dependent on 5 L presented to the ED with substernal chest pain and shortness of breath that was occurring all day yesterday that acutely worsened overnight while she was doing dialysis.no abdominal pain, no cough, no fatigue, no fever, no headache, no nausea, no numbness, no palpitations, no vomiting and no weakness.Adenocarcinoma of left lung. CXR revealed Infiltrative changes in the region of left upper lobe.  ESRD. Cr 11.03.Chronic respiratory failure with hypoxia.  NSTEMI.  Troponin level 3.18. SpO2 95%. Treatment: Solu=Medrol, oxygen, breathing treatments, Spiriva, metoprolol, dialysis, lasix, asprin. Admitted to hospice.  Expired on 6/2.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Condition aggravated, Death, Dialysis, Dyspnoea
Clinical narrative: Patient is fully vaccinated. COVID positive on 5/9/2022. 67-year-old female, history of end-stage renal disease on peritoneal dialysis daily, CAD hypertension hyperlipidemia, COPD and CHF, oxygen dependent on 5 L presented to the ED with substernal chest pain and shortness of breath that was occurring all day yesterday that acutely worsened overnight while she was doing dialysis.no abdominal pain, no cough, no fatigue, no fever, no headache, no nausea, no numbness, no palpitations, no vomiting and no weakness.Adenocarcinoma of left lung. CXR revealed Infiltrative changes in the region of left upper lobe.  ESRD. Cr 11.03.Chronic respiratory failure with hypoxia.  NSTEMI.  Troponin level 3.18. SpO2 95%. Treatment: Solu=Medrol, oxygen, breathing treatments, Spiriva, metoprolol, dialysis, lasix, asprin. Admitted to hospice.  Expired on 6/2.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: End stage renal disease, Lung adenocarcinoma, Lung infiltration, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient is fully vaccinated. COVID positive on 5/9/2022. 67-year-old female, history of end-stage renal disease on peritoneal dialysis daily, CAD hypertension hyperlipidemia, COPD and CHF, oxygen dependent on 5 L presented to the ED with substernal chest pain and shortness of breath that was occurring all day yesterday that acutely worsened overnight while she was doing dialysis.no abdominal pain, no cough, no fatigue, no fever, no headache, no nausea, no numbness, no palpitations, no vomiting and no weakness.Adenocarcinoma of left lung. CXR revealed Infiltrative changes in the region of left upper lobe.  ESRD. Cr 11.03.Chronic respiratory failure with hypoxia.  NSTEMI.  Troponin level 3.18. SpO2 95%. Treatment: Solu=Medrol, oxygen, breathing treatments, Spiriva, metoprolol, dialysis, lasix, asprin. Admitted to hospice.  Expired on 6/2.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: Patient is fully vaccinated. COVID positive on 5/9/2022. 67-year-old female, history of end-stage renal disease on peritoneal dialysis daily, CAD hypertension hyperlipidemia, COPD and CHF, oxygen dependent on 5 L presented to the ED with substernal chest pain and shortness of breath that was occurring all day yesterday that acutely worsened overnight while she was doing dialysis.no abdominal pain, no cough, no fatigue, no fever, no headache, no nausea, no numbness, no palpitations, no vomiting and no weakness.Adenocarcinoma of left lung. CXR revealed Infiltrative changes in the region of left upper lobe.  ESRD. Cr 11.03.Chronic respiratory failure with hypoxia.  NSTEMI.  Troponin level 3.18. SpO2 95%. Treatment: Solu=Medrol, oxygen, breathing treatments, Spiriva, metoprolol, dialysis, lasix, asprin. Admitted to hospice.  Expired on 6/2.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Pain, Pyrexia, Rash, Rash erythematous
Clinical narrative: High fever and shivers beginning about 15 hours after injection lasting about 4 hours.   All-over body sunburn-looking rash Ears ringing Body aches
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Tinnitus
Clinical narrative: High fever and shivers beginning about 15 hours after injection lasting about 4 hours.   All-over body sunburn-looking rash Ears ringing Body aches
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: patient was only 17, no side effects recorded
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Fatigue, Illness
Clinical narrative: Patient is fully vaccinated. He did test positive for COVID this morning.The patient developed body aches fever and general illness yesterday.No headache but has rhinorrhea sore throat and a mild cough.  No vomiting or diarrhea. + fatigue, + fever.  HR 128. CXR: No acute lung process. Treatment: fluids, Toradol. O2 sat 95%. Discharged home.  Recommend rest.  Zinc and vitamin D.  Self-isolation for 10 days.  Watch for shortness of breath.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Patient is fully vaccinated. He did test positive for COVID this morning.The patient developed body aches fever and general illness yesterday.No headache but has rhinorrhea sore throat and a mild cough.  No vomiting or diarrhea. + fatigue, + fever.  HR 128. CXR: No acute lung process. Treatment: fluids, Toradol. O2 sat 95%. Discharged home.  Recommend rest.  Zinc and vitamin D.  Self-isolation for 10 days.  Watch for shortness of breath.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, C-reactive protein, Fatigue, Pain
Clinical narrative: New onset joint pain, achy and fatigued. Monitored symptoms has not resolved seen at PCP now have Positive AHA, CRP and sent to Rheumatology
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Adenovirus test positive, Blood glucose increased, Blood lactic acid, Blood pH decreased, Blood sodium decreased
Clinical narrative: Exposed to COVID at school. Symptoms May 25th, to emergency care, given Tessalon pearles, fluticasone, and Tylenol. Progressed, back to ED next day. Given IV acetaminophen and IV saline bolus, decadron and reglan. Discharged with acetaminophen, ibuprophen, phenergan and zofran. Still progressed, found unresponsive on May 28th, to ED. Unresponsive, brain dead. May 28: redesivir, dexamethasone, vancomycin ceftriaxone, and metronidazole.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Brain death, Brain herniation, Computerised tomogram head abnormal, Echocardiogram abnormal, Electroencephalogram abnormal
Clinical narrative: Exposed to COVID at school. Symptoms May 25th, to emergency care, given Tessalon pearles, fluticasone, and Tylenol. Progressed, back to ED next day. Given IV acetaminophen and IV saline bolus, decadron and reglan. Discharged with acetaminophen, ibuprophen, phenergan and zofran. Still progressed, found unresponsive on May 28th, to ED. Unresponsive, brain dead. May 28: redesivir, dexamethasone, vancomycin ceftriaxone, and metronidazole.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Enterovirus test positive, Exposure to SARS-CoV-2, Human rhinovirus test positive, Malaise, Mitral valve incompetence
Clinical narrative: Exposed to COVID at school. Symptoms May 25th, to emergency care, given Tessalon pearles, fluticasone, and Tylenol. Progressed, back to ED next day. Given IV acetaminophen and IV saline bolus, decadron and reglan. Discharged with acetaminophen, ibuprophen, phenergan and zofran. Still progressed, found unresponsive on May 28th, to ED. Unresponsive, brain dead. May 28: redesivir, dexamethasone, vancomycin ceftriaxone, and metronidazole.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Respiratory viral panel, SARS-CoV-2 test positive, Tricuspid valve incompetence, Unresponsive to stimuli
Clinical narrative: Exposed to COVID at school. Symptoms May 25th, to emergency care, given Tessalon pearles, fluticasone, and Tylenol. Progressed, back to ED next day. Given IV acetaminophen and IV saline bolus, decadron and reglan. Discharged with acetaminophen, ibuprophen, phenergan and zofran. Still progressed, found unresponsive on May 28th, to ED. Unresponsive, brain dead. May 28: redesivir, dexamethasone, vancomycin ceftriaxone, and metronidazole.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Exposed to COVID at school. Symptoms May 25th, to emergency care, given Tessalon pearles, fluticasone, and Tylenol. Progressed, back to ED next day. Given IV acetaminophen and IV saline bolus, decadron and reglan. Discharged with acetaminophen, ibuprophen, phenergan and zofran. Still progressed, found unresponsive on May 28th, to ED. Unresponsive, brain dead. May 28: redesivir, dexamethasone, vancomycin ceftriaxone, and metronidazole.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia, Dyspnoea
Clinical narrative: Patient is fully vaccinated and boosted. COVID positive test 5/10/2022 on admission to hospital.Admitting DX: general weakness, fever, COVID.  Acute respiratory failure. Patient presented with shortness of breath and hypoxic from covid-19 infection with suspected pneumonia. ID and pulmonary were consulted. He was treated with 3 day course of IV remdesivir, IV steroids. He clinically improved and was discharged home once cleared by pulmonary.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient is fully vaccinated and boosted. COVID positive test 5/10/2022 on admission to hospital.Admitting DX: general weakness, fever, COVID.  Acute respiratory failure. Patient presented with shortness of breath and hypoxic from covid-19 infection with suspected pneumonia. ID and pulmonary were consulted. He was treated with 3 day course of IV remdesivir, IV steroids. He clinically improved and was discharged home once cleared by pulmonary.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Product preparation issue
Clinical narrative: Pentacel dual vials - only the diluent/liquid was administered. It was not reconstituted with the HIB portion of the vaccine duo.   There was no adverse medical event for the patient.  The full vaccine dosing was given on 4/20/2022 without medical event
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Fatigue, Gait inability
Clinical narrative: Patient is fully vaccinated and boosted.  COVID positive 5/10/2022 on admission to the hospital. 77 year old male with history of BPH, depression presenting to medical facility 5/10/22 with a complaint of fatigue. Patient reports that he has been unable to walk due to bilateral leg weakness, with new onset cough. Patient states his inability to ambulate has progressed over the past 6 weeks. . His previous functional status was adequate, with independence in all activities. No mental status changes. SpO2 90%. CXR: There is no acute process. Remdesivir given for 3 days. Discharged home.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, SARS-CoV-2 test positive
Clinical narrative: Patient is fully vaccinated and boosted.  COVID positive 5/10/2022 on admission to the hospital. 77 year old male with history of BPH, depression presenting to medical facility 5/10/22 with a complaint of fatigue. Patient reports that he has been unable to walk due to bilateral leg weakness, with new onset cough. Patient states his inability to ambulate has progressed over the past 6 weeks. . His previous functional status was adequate, with independence in all activities. No mental status changes. SpO2 90%. CXR: There is no acute process. Remdesivir given for 3 days. Discharged home.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Pain, Productive cough, Sputum discoloured
Clinical narrative: Patient is fully vaccinated and boosted. Patient was diagnsed with COVID this past week. Presents to the ED on 5/10/2022 with productive cough with yellow sputum.  No fever. no chills, nausea, vomiting.  + for body aches. BP 138/77  | Pulse 83  | Temp 98.2 °F (36.8 °C) (Oral)  | Resp 18  | SpO2 98% Clinically, the patient has clear lungs bilaterally with stable vital signs.  Chest x-ray was performed which again demonstrates no evidence of pneumonia.Discharged to home.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hallucination, Tremor
Clinical narrative: Hallucinations, chills, shaking
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, COVID-19, Chest X-ray normal, Chest pain, Chills
Clinical narrative: Patient is fully vaccinated and boosted twice.  COVID positive on 5/10/2022.72-year-old male who presents complaining of chest pain that is since resolved.  Patient tested positive for COVID earlier today and was getting his infusion at Dr's office.  States that he thinks that his chest pain was brought on by anxiety.  States that he is multiple needles and developed chest pain.  Symptoms resolved.  He was given aspirin in route.  He does have a history of CABG. Positive for chills, fatigue, cough and chest pain. BP 153/85  | Pulse 60  | Temp 98.8 °F (37.1 °C)  | Resp 18  | Ht 198.1 cm (6' 6")  | Wt 99.8 kg (220 lb)  | SpO2 97% EKG: sinus bradycardia, no signs of ischemia and no infarction. Medications: fluid and Nitro.  CXR: acutely unremarkable radiograph of the chest.Left AMA.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Electrocardiogram abnormal, Fatigue, SARS-CoV-2 test positive, Sinus bradycardia
Clinical narrative: Patient is fully vaccinated and boosted twice.  COVID positive on 5/10/2022.72-year-old male who presents complaining of chest pain that is since resolved.  Patient tested positive for COVID earlier today and was getting his infusion at Dr's office.  States that he thinks that his chest pain was brought on by anxiety.  States that he is multiple needles and developed chest pain.  Symptoms resolved.  He was given aspirin in route.  He does have a history of CABG. Positive for chills, fatigue, cough and chest pain. BP 153/85  | Pulse 60  | Temp 98.8 °F (37.1 °C)  | Resp 18  | Ht 198.1 cm (6' 6")  | Wt 99.8 kg (220 lb)  | SpO2 97% EKG: sinus bradycardia, no signs of ischemia and no infarction. Medications: fluid and Nitro.  CXR: acutely unremarkable radiograph of the chest.Left AMA.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in Freezer
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed breakthrough  COVID-19 (Pfizer) 1 02/11/2021 Pfizer EM9810   COVID-19 (Pfizer) 2 03/04/2021   Pfizer EN6201   COVID-19 (Pfizer) 3 10/13/2021 Pfizer FF2590
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed breakthrough case  COVID-19 (Moderna) 1 03/09/2021 Health Center - Moderna 036A21A   COVID-19 (Moderna) 2 05/20/2021 Health Center - Moderna 047C21A   COVID-19 (Moderna) 3 01/13/2022 Health Center - Moderna 084J21A
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Nasal congestion, Nasopharyngitis, SARS-CoV-2 test, Throat irritation
Clinical narrative: Approximately about 1 month after my 4th dose vaccination I contracted COVID-19 and had the following symptoms: Scratchy throat,Stuffy nose, Cold. I took Dayquil, Aspirin and Theraflu and Vicks vaporub at night. I had a televisit with my Doctor and was prescribe to take Paxlovid for 5 days. I have finished all 5 days of Paxlovid and I have noticed that I am feeling so much better each day.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed Breakthrough  COVID-19 (Janssen) 1 03/20/2021 Hospital Janssen 1802068   COVID-19 (Janssen) 2 11/23/2021 County Health Department Janssen 211D21A
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive covid. Pt that was fully vaccinated.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Bundle branch block left, COVID-19, Chest X-ray normal, Chest discomfort, Electrocardiogram abnormal
Clinical narrative: Patient is fully vaccinated and boosted twice.  COVID positive on 5/10/2022 at ED vist. He has URI congestion, no cough, fever, chills or dyspnea.  Today he had chest pressure, lasted about two hours. No diaphoresis or radiation. No abdominal pain, myalgias, headache or diarrhea. BP (!) 146/38  | Pulse 68  | Temp 99 °F (37.2 °C) (Oral)  | Resp 18  | Ht 180.3 cm (5' 11")  | Wt 99.8 kg (220 lb)  | SpO2 97%  EKG: Sinus brady rate 56.  Left BBB. Cr 1.76. Troponin normal. CXR: No acute pulmonary process. Stable, discharged with instructions.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Sinus bradycardia, Troponin normal, Upper respiratory tract infection
Clinical narrative: Patient is fully vaccinated and boosted twice.  COVID positive on 5/10/2022 at ED vist. He has URI congestion, no cough, fever, chills or dyspnea.  Today he had chest pressure, lasted about two hours. No diaphoresis or radiation. No abdominal pain, myalgias, headache or diarrhea. BP (!) 146/38  | Pulse 68  | Temp 99 °F (37.2 °C) (Oral)  | Resp 18  | Ht 180.3 cm (5' 11")  | Wt 99.8 kg (220 lb)  | SpO2 97%  EKG: Sinus brady rate 56.  Left BBB. Cr 1.76. Troponin normal. CXR: No acute pulmonary process. Stable, discharged with instructions.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed breakthrough  COVID-19 (Pfizer) 1 03/01/2021 Pharmacy  Pfizer EN6200   COVID-19 (Pfizer) 2 03/22/2021 Pharmacy  Pfizer ER2613   COVID-19 (Pfizer) 3 10/14/2021 Health Department Pfizer FF2590
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Exposure to SARS-CoV-2, Respiratory tract congestion
Clinical narrative: Breakthrough case of Covid. Tested positive on 05/25/2022- home test. My partner has cancer, so we live a very Covid cautious life. After swim team we went to get Covid tested before a road trip on 05/24/2022-PCR test came back negative. That night he was a little sniffy, I did not worry to much about it, thought it was allergies. The next morning, we were getting ready to leave for a road trip. We received notification from a neighbor that her son was positive, so we all tested, and his test came up positive immediately. He had a little congestion, and he was coughing, and had stridor so we brought him to the ER this was Friday 05/27/2022 12:30am when he woke up with difficulty breathing, we went to the Hospital, dx croup. Given steroids and the cough is almost gone now.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Stridor, Vaccine breakthrough infection
Clinical narrative: Breakthrough case of Covid. Tested positive on 05/25/2022- home test. My partner has cancer, so we live a very Covid cautious life. After swim team we went to get Covid tested before a road trip on 05/24/2022-PCR test came back negative. That night he was a little sniffy, I did not worry to much about it, thought it was allergies. The next morning, we were getting ready to leave for a road trip. We received notification from a neighbor that her son was positive, so we all tested, and his test came up positive immediately. He had a little congestion, and he was coughing, and had stridor so we brought him to the ER this was Friday 05/27/2022 12:30am when he woke up with difficulty breathing, we went to the Hospital, dx croup. Given steroids and the cough is almost gone now.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in Freezer
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death, Laboratory test abnormal
Clinical narrative: Pt. Deceased cant confirm if in which system.  1st dose Moderna 1/7/2021 - 026L20a 2nd Dose Moderna 2/4/2021 -  012L20A
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Pt. Deceased cant confirm if in which system.  1st dose Moderna 1/7/2021 - 026L20a 2nd Dose Moderna 2/4/2021 -  012L20A
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Bone pain, Fatigue, Headache, Immediate post-injection reaction, Neck pain
Clinical narrative: She got her vaccine, immediately she had an ache in the left arm, was given in upper part of arm.  About 2-3 AM she woke up with pain in her gluteal region.  It was generalized achiness, pain in her neck, headache, tired.  Headaches from one temple, around back of head to the other temple.  She Emailed her dr. and told him to report it.  She took some Ibuprofen.  She went for a walk which made the headache worse.  The achiness was the same as well as the bone pain.  The headache is more in the back of the skull type headache.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pain in extremity, Sleep disorder
Clinical narrative: She got her vaccine, immediately she had an ache in the left arm, was given in upper part of arm.  About 2-3 AM she woke up with pain in her gluteal region.  It was generalized achiness, pain in her neck, headache, tired.  Headaches from one temple, around back of head to the other temple.  She Emailed her dr. and told him to report it.  She took some Ibuprofen.  She went for a walk which made the headache worse.  The achiness was the same as well as the bone pain.  The headache is more in the back of the skull type headache.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Chest X-ray normal, Chest discomfort, Chills
Clinical narrative: Patient is fully vaccinated. 28-year-old female presents to the ED complaining of fatigue, generalized weakness, dyspnea.  States that she was diagnosed with COVID 3 days ago.  Has been having symptoms for the last 4 to 5 days.  Also has a cough productive of yellow sputum.  Having mild generalized chest tightness.  On and off subjective fever and chills.  Also having on and off mild generalized abdominal pain.  No dysuria hematuria or polyuria.  Symptoms are moderate in severity.  She says that she was getting better and then worsened yesterday.  No leg pain or swelling.  No history of DVT/PE.BP 106/77  | Pulse 80  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 18  | Ht 177.8 cm (5' 10")  | Wt 77.1 kg (170 lb)  | SpO2 100% Troponin less than 0.01.  UA negative for UTI.  Hepatic function and lipase normal.  CBC and chest x-ray unremarkable.She was given IV fluids, Toradol Zofran and Robaxin. Discharged home.